NCT00365300
Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)
See it on ClinicalTrials.gov ↗106 people
35.8%
64.2%
38 womenmiddle line = equal numbers68 men
- Phase
- PHASE3
- Paid for by
- Wyeth is now a wholly owned subsidiary of Pfizer
- Finished
- 2007-11
- Health conditions
- Gastroesophageal Reflux
- Who could join
- Anyone
- Ages
- 28 Days – 11 Months
- Average age
- mean 5.09 months
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 11 Months.”
Study titles and rules are shown in their original English.